Form 4 for LUCD Lucid Diagnostics Inc.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001062993-24-003693 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-15 | LUCD | PAVmed Inc. | 10% | J - Other | — | -3.33M | 31.30M | -10% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | J | D | 3,331,747 | — | 31,302,444 | D | — | — | (F1) Distribution by the Reporting Person as a pro rata dividend to the owners of common and preferred stock of the Reporting Person. |